Larotrectinib is a selective inhibitor. It’s made for tumors that have NTRK gene fusions, especially those involving TRKA, TRKB, and TRKC. The dose adults should take is 100 mg, twice a day.
For kids, the dose is based on their body surface area. You’ve got three options: 25 mg or 100 mg capsules, or a 20 mg/mL liquid. The medicine comes in packs with 60 capsules each.
It’s for adults and kids who have solid tumors with NTRK fusions that can’t be removed or have spread.
